- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 138.28M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $14.9M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $8.87M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $21.17M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $15.17M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $124.15M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $132.75M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $131.45M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $140.4M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $43.48M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $43.48M |
| Capex | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$13.89M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $157.06M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $148.54M |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.25M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $9.52M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$10.79M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$12.77M |